Physician profile
Athanasios Larkin
NPI 1073262556
$1,274.32
in general payments reported to CMS, 2019-2025
15 companies · $863 in 2025
The $863 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $195 · 2023: $142 · 2024: $73.82 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $233.24 | 2025 | General - Therapies, Emblem Mri S-Icd |
| Medtronic, INC. | $215.55 | 2022-2025 | Corevalve Evolut R |
| Insmed, INC. | $136.92 | 2022 | |
| Abiomed | $127.12 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.88 | 2023 | Entyvio |
| Philips North America LLC | $103.66 | 2025 | Labosys |
| Shockwave Medical, INC | $102.09 | 2025 | |
| Janssen Pharmaceuticals, INC | $73.82 | 2024 | Xarelto |
| Genzyme Corporation | $33.66 | 2025 | |
| Biosense Webster, INC. | $30.48 | 2025 | Na |
| Abbvie INC. | $21.56 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.93 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.17 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.51 | 2025 | Jardiance |
| Radius Health, INC. | $17.73 | 2025 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Larkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.